Biological markers for non-small cell lung cancer patient selection for epidermal growth factor receptor tyrosine kinase inhibitor therapy

被引：48

作者：

Bunn, Paul A., Jr.

Dziadziuszko, Rafal

Varella-Garcia, Marileila

Franklin, WilburA.

Witta, Samir E.

Kelly, Karen

Hirsch, Fred R.

机构：

[1] Univ Colorado, Ctr Canc, Dept Med, Aurora, CO 80045 USA

[2] Univ Colorado, Ctr Canc, Dept Pathol, Aurora, CO 80045 USA

[3] Univ Colorado, Hlth Sci Ctr, Aurora, CO USA

[4] Med Univ Gdansk, Dept Oncol & Radiotherapy, Gdansk, Poland

来源：

CLINICAL CANCER RESEARCH | 2006年 / 12卷 / 12期

关键词：

D O I：

10.1158/1078-0432.CCR-06-0261

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：3652 / 3656

页数：5

共 45 条

[1]

Bailey L. Renee, 2003, Proceedings of the American Association for Cancer Research Annual Meeting, V44, P1362

[2] Critical update and emerging trends in epidermal growth factor receptor targeting in cancer [J].

Baselga, J ;

Arteaga, CL .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (11) :2445-2459

[3] The female gender has a positive effect on survival independent of background life expectancy following surgical resection of primary non-small cell lung cancer:: a study of absolute and relative survival over 15 years [J].

Båtevik, R ;

Grong, K ;

Segadal, L ;

Stangeland, L .

LUNG CANCER, 2005, 47 (02) :173-181

[4] Epidermal growth factor receptor mutations and gene amplification in non-small-cell lung cancer: Molecular analysis of the IDEAL/INTACT gefitinib trials [J].

Bell, DW ;

Lynch, TJ ;

Haserlat, SM ;

Harris, PL ;

Okimoto, RA ;

Brannigan, BW ;

Sgroi, DC ;

Muir, B ;

Riemenschneider, MJ ;

Iacona, RB ;

Krebs, AD ;

Johnson, DH ;

Giaccone, G ;

Herbst, RS ;

Manegold, C ;

Fukuoka, M ;

Kris, MG ;

Baselga, J ;

Ochs, JS ;

Haber, DA .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (31) :8081-8092

[5] HER3 genomic gain and sensitivity to gefitinib in advanced non-small-cell lung cancer patients [J].

Cappuzzo, F ;

Toschi, L ;

Domenichini, I ;

Bartolini, S ;

Ceresoli, GL ;

Rossi, E ;

Ludovini, V ;

Cancellieri, A ;

Magrini, E ;

Bemis, L ;

Franklin, WA ;

Crino, L ;

Bunn, PA ;

Hirsch, FR ;

Varella-Garcia, M .

BRITISH JOURNAL OF CANCER, 2005, 93 (12) :1334-1340

[6] Increased HER2 gene copy number is associated with response to gefitinib therapy in epidermal growth factor receptor-positive non-small-cell lung cancer patients [J].

Cappuzzo, F ;

Varella-Garcia, M ;

Shigematsu, H ;

Domenichini, I ;

Bartolini, S ;

Ceresoli, GL ;

Rossi, E ;

Ludovini, V ;

Gregorc, V ;

Toschi, L ;

Franklin, WA ;

Crino, L ;

Gazdar, AF ;

Bunn, RA ;

Hirsch, FR .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (22) :5007-5018

[7] Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer [J].

Cappuzzo, F ;

Hirsch, FR ;

Rossi, E ;

Bartolini, S ;

Ceresoli, GL ;

Bemis, L ;

Haney, J ;

Witta, S ;

Danenberg, K ;

Domenichini, I ;

Ludovini, V ;

Magrini, E ;

Gregorc, V ;

Doglioni, C ;

Sidoni, A ;

Tonato, M ;

Franklin, WA ;

Crino, L ;

Bunn, PA ;

Varella-Garcia, M .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (09) :643-655

[8] Akt phosphorylation and gefitinib efficacy in patients with advanced non-small-cell lung cancer [J].

Cappuzzo, F ;

Magrini, E ;

Ceresoli, GL ;

Bartolini, S ;

Rossi, E ;

Ludovini, V ;

Gregorc, V ;

Ligorio, C ;

Cancellieri, A ;

Damiani, S ;

Spreafico, A ;

Paties, CT ;

Lombardo, L ;

Calandri, C ;

Bellezza, G ;

Tonato, M ;

Crinò, L .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (15) :1133-1141

[9] A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer [J].

Coombes, RC ;

Hall, E ;

Gibson, LJ ;

Paridaens, R ;

Jassem, J ;

Delozier, T ;

Jones, SE ;

Alvarez, I ;

Bertelli, G ;

Ortmann, O ;

Coates, AS ;

Bajetta, E ;

Dodwell, D ;

Coleman, RE ;

Fallowfield, LJ ;

Mickiewicz, E ;

Andersen, J ;

Lonning, PE ;

Cocconi, G ;

Stewart, A ;

Stuart, N ;

Snowdon, CF ;

Carpentieri, M ;

Massimini, G ;

Bliss, JM .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (11) :1081-1092

[10] Epidermal growth factor receptor activating mutations in Spanish gefitinib-treated non-small-cell lung cancer patients [J].

Cortes-Funes, H ;

Gomez, C ;

Rosell, R ;

Valero, P ;

Garcia-Giron, C ;

Velasco, A ;

Izquierdo, A ;

Diz, P ;

Camps, C ;

Castellanos, D ;

Alberola, V ;

Cardenal, F ;

Gonzalez-Larriba, JL ;

Vieitez, JM ;

Maeztu, I ;

Sanchez, JJ ;

Queralt, C ;

Mayo, C ;

Mendez, P ;

Moran, T ;

Taron, M .

ANNALS OF ONCOLOGY, 2005, 16 (07) :1081-1086

← 1 2 3 4 5 →